68Ga PET/CT Imaging in Breast Cancer Patients
NCT05622227
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST:
Drug: 68Ga-P16-093
Sponsor
Peking Union Medical College Hospital